Inicio Área de profesionales Artículos publicados Docetaxel/Gemcitabine Administered Every Other Week as First-Line Treatment for Metastatic Breast Cancer: Final Results of a Phase II Trial

Docetaxel/Gemcitabine Administered Every Other Week as First-Line Treatment for Metastatic Breast Cancer: Final Results of a Phase II Trial

Correo electrónico Imprimir

Amadeu Pelegrí, Lourdes Calvo, Antonio Anton, Jose I. Mayordomo, Jesús Florián, Santiago Vazquez, Angels Arcusa, Marta Martin-Richard, Jose L. Bayo, Eva Carrasco, Javier Virizuela. Docetaxel/Gemcitabine Administered Every Other Week as First-Line Treatment for Metastatic Breast Cancer: Final Results of a Phase II Trial. Clinical Breast Cancer 2005; 6(5):433-438.

Para más información vaya al siguiente enlace:

http://cigjournals.metapress.com/content/k403r1hh6k323681/